Maaike van Zon

The Netherlands Cancer Institute — Netherlands

Immunology and Microbiology · Life Sciences

11h-index2.8kcitations23works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(10), CAR-T cell therapy research(10), Tuberculosis Research and Epidemiology(7), Mycobacterium research and diagnosis(6), Cancer Immunotherapy and Biomarkers(5)

Publications23 total

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy
Nature Communications·2026Open Access
Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial
British journal of surgery·2025· 2 citedOpen Access
57P Anatomical location of metastasis and composition of the final infusion product in metastatic melanoma (MM) patients treated with tumor-infiltrating lymphocytes (TIL)
Immuno-Oncology Technology·2023· 1 citedOpen Access
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
New England Journal of Medicine·2022· 475 citedOpen Access
MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial
Immuno-Oncology Technology·2022· 36 citedOpen Access
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells
Cell Reports·2021· 70 citedOpen Access
IL-1R1-Dependent Signals Improve Control of Cytosolic Virulent Mycobacteria <i>In Vivo</i>
mSphere·2021· 5 citedOpen Access
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
Journal for ImmunoTherapy of Cancer·2020· 185 citedOpen Access
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8 <sup>+</sup> T cells
2020· 5 citedOpen Access
Results of a phase I trial with MART-1 T cell receptor modified T cells in patients with metastatic melanoma
Annals of Oncology·2019· 6 citedOpen Access
Abstract B205: Adoptive transfer of autologous T-cells, modified with a MART-1 specific TCR and cultured in IL-7/IL-15, for the treatment of metastatic melanoma patients
Cancer Immunology Research·2019
Randomized phase III study comparing a non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor infiltrating lymphocytes and interleukine-2 to standard ipilimumab treatment in metastatic melanoma
Annals of Oncology·2018Open Access
Multicenter phase I/IIa study using T cell receptor gene therapy in metastatic melanoma.
Journal of Clinical Oncology·2018· 2 cited
Subcellular localization of <i>M. tuberculosis</i> in vivo and effect of the adaptive immunity
Ultrastructural Pathology·2017· 1 cited
Abstract PL01-03: TIL therapy in the era of immune checkpoint blockade
Molecular Cancer Therapeutics·2015
Mannan core branching of lipo(arabino)mannan is required for mycobacterial virulence in the context of innate immunity
Cellular Microbiology·2013· 29 citedOpen Access
ESX‐1‐mediated translocation to the cytosol controls virulence of mycobacteria
Cellular Microbiology·2012· 408 citedOpen Access
Mycobacterial Secretion Systems ESX-1 and ESX-5 Play Distinct Roles in Host Cell Death and Inflammasome Activation
The Journal of Immunology·2011· 146 citedOpen Access
Direct Visualization by Cryo-EM of the Mycobacterial Capsular Layer: A Labile Structure Containing ESX-1-Secreted Proteins
PLoS Pathogens·2010· 303 citedOpen Access
The ESX-5 Secretion System of <i>Mycobacterium marinum</i> Modulates the Macrophage Response
The Journal of Immunology·2008· 140 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

John B.A.G. Haanen(11), Nicole N. van der Wel(10), Maartje W. Rohaan(9), Bastiaan Nuijen(9), Joost H. van den Berg(8), Ton N. Schumacher(8), Peter J. Peters(7), Christian U. Blank(7), Renate de Boer(7), Wilbert Bitter(6), Diederik van de Beek(5), Marnix H. Geukes Foppen(5), Johannes V. van Thienen(5), Karin de Punder(5), Raquel Gomez-Eerland(5), Noor A. M. Bakker(5), Loes M. Pronk(5), Troels Holz Borch(4), Jos H. Beijnen(4), Ferry Lalezari(4)